Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Standardized Attending Morning Rounds

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT01931553Not ApplicableCompleted

A Pragmatic Cluster Randomized Controlled Trial to Standardize Attending Morning Rounds in Medicine

NCT01306344UnknownPrimary

Qualitative Descriptive Study of the Meaning of the Ward Round

Showing all 2 trials

Research Network

Common Treatments

  • Standardized Attending Morning Rounds1

Active Sponsors

  • University of California, San Francisco1
  • Oslo University College1
  • Oslo University Hospital1

Top Investigators

Related Conditions

  • Quality Improvement1
  • Hospitalization1
  • Morning Rounds1
  • Inpatients1

Activity Timeline